Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000181122 | SCV000233398 | pathogenic | not provided | 2024-11-04 | criteria provided, single submitter | clinical testing | Identified in a patient belonging to a cohort of individuals with vascular Ehlers-Danlos syndrome in published literature (PMID: 24922459); Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24922459) |
Labcorp Genetics |
RCV000087562 | SCV000829906 | pathogenic | Ehlers-Danlos syndrome, type 4 | 2023-12-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg326*) in the COL3A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL3A1 are known to be pathogenic (PMID: 24922459). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Ehlers-Danlos syndrome, type IV (PMID: 24922459). ClinVar contains an entry for this variant (Variation ID: 101324). For these reasons, this variant has been classified as Pathogenic. |
Collagen Diagnostic Laboratory, |
RCV000087562 | SCV000120452 | pathogenic | Ehlers-Danlos syndrome, type 4 | no assertion criteria provided | clinical testing |